Commercialization Partnership Deal
Oct 20 (Reuters) - Redhill Biopharma Ltd 2RHy.F: REDHILL'S TALICIA® SECURES $4 MILLION STRATEGIC INVESTMENT AND U.S. CO-COMMERCIALIZATION PARTNERSHIP DEAL REDHILL BIOPHARMA LTD - CUMBERLAND INVESTS $4 MILLION FOR 30% STAKE IN CO'S GLOBAL TALICIA BUSINESS Source text: ID:nPn2C4NSta Further company coverage: [2RHy.F] ((Reuters.Briefs@thomsonreuters.com;))
Recent news on Cumberland Pharmaceuticals
See all newsBrief: Cumberland Pharmaceuticals Announces Assist-Ssc Trial Top-Line Results
Cumberland Pharmaceuticals Q2 loss widens after Apotex transaction
Brief: Cumberland Pharmaceuticals Announces Special Dividend Of $1.50 Per Share
Cumberland Pharmaceuticals Q1 revenue up 5%; to sell FDA‑approved brands to Apotex for $100 mln
NASDAQ RESUMED AT 09:38 AM